Electronic Resource

Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up

التفاصيل البيبلوغرافية
العنوان: Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up
المؤلفون: Pioltelli, M, Pungolino, E, D'Adda, M, Elena, C, Borin, L, Perego, A, Malato, S, Spina, F, Artale, S, Carraro, M, Orofino, N, Anghilieri, M, Farina, M, Latargia, M, Iurlo, A, Trojani, A, Turrini, M, Caramella, M, Spedini, P, Rossi, G, Morra, E, Cairoli, R, Pioltelli ML, Pungolino E, D'adda M, Elena C, Borin LM, Perego A, Malato S, Spina F, Artale S, Carraro M, Orofino N, Anghilieri M, Farina M, Latargia ML, Iurlo A, Trojani A, Turrini M, Caramella M, Spedini P, Rossi G, Morra E, Cairoli R
بيانات النشر: 2018
نوع الوثيقة: Electronic Resource
مصطلحات الفهرس: Hematology, info:eu-repo/semantics/conferenceObject
URL: https://hdl.handle.net/10281/409417
info:eu-repo/semantics/altIdentifier/wos/WOS:000454842806294
60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018
volume:132
issue:S1
journal:BLOOD
الاتاحة: Open access content. Open access content
ملاحظة: English
Other Numbers: ITBAO oai:boa.unimib.it:10281/409417
10.1182/blood-2018-99-113496
1376713946
المصدر المساهم: BICOCCA OPEN ARCH
From OAIster®, provided by the OCLC Cooperative.
رقم الانضمام: edsoai.on1376713946
قاعدة البيانات: OAIster